In this episode, we dive into the groundbreaking work of Health Care Originals (HCO), a healthtech company revolutionizing the management of respiratory conditions like asthma and COPD. With a proprietary AI-driven platform and innovative wearable technology, HCO is redefining how we approach respiratory care—making it predictive, preventative, and personalized.Join us as we explore the company’s journey, the $83 billion market opportunity, and the clinical outcomes that have transformed patients' lives. From its robust intellectual property portfolio to its mission-driven leadership team, HCO is a compelling case for the future of healthcare.We’ll also discuss HCO’s equity crowdfunding campaign on Wefunder, offering investors the chance to support a high-impact venture poised for significant growth. Tune in to learn how HCO sets a new standard in respiratory health management and why this might be an investment opportunity worth considering.Disclaimer: This episode is for informational purposes only and does not constitute investment advice. Hosted on Acast. See acast.com/privacy for more information.

Ver todos los episodios